
Yashpal Singh Malik
Deputy Director General (Agricultural Education)Indian Council of Agricultural Research, Headquarters, New Delhi , India
Submitted
2021/02/20First Online
2021/06/12doi
10.18805/IJAR.B-4432Cite article - M. Abhilash, T.R. Kannaki, E. Priyanka, Santosh Haunshi. (2021). Immunogenicity and Protective Efficacy of Iron-inactivated Pasteurella multocida A:1 Vaccine against Fowl Cholera in Backyard Chicken. Indian Journal of Animal Research. 60(1): 125–129. doi: 10.18805/IJAR.B-4432
Background: Fowl cholera is a highly fatal, contagious bacterial disease that incurs significant economic loss in commercial as well as back-yard poultry. Vaccination is the most effective way in controlling this disease. In this study, we prepared and evaluated the immunogenicity of iron-inactivated Pasteurella multocida A:1 vaccine and its protective efficacy against fowl cholera experimental infection in backyard chicken.
Methods: Scaled up Pasteurella multocida A:1 culture with 5 x 108 CFU/ml equivalent to 2.5 mg of antigen per dose was used for preparation of experimental vaccines. Formalin inactivated and mixed with APS adjuvant (FIA), formalin inactivated-Freund adjuvant (FIF), Iron inactivated and adjuvanted with iron (III), Iron inactivated from iron supplemented media and adjuvanted with iron (ISII) and commercial oil emulsion vaccine (CV) were used in the study. A total of 120 Vanaraja birds (n=20/group) of 2 weeks age were immunized with these vaccine and booster were given at 3 rd and 6 th week with respective vaccine. Specific antibody titers were assessed by iELISA in the serum at weekly intervals. The birds were challenged (n=6/group) with 5x10 4 CFU/ml of virulent isolate by intraperitoneal route and morbidity, mortality percentage were observed.
Result: Protective antibody titers were induced by iron inactivated vaccine from 4 th week of immunization and upon booster doses it induced significantly higher (P<0.05) antibody response. The iron inactivated experimental vaccine gave equivalent protection as that of commercial vaccine upon challenge infection.
true
Distinguished scholars and subject experts committed to editorial excellence, scientific integrity and rigorous peer review.
View Full Board